China Biologic Products (CBPO) Tops Q1 EPS by 8c

China Biologic Products (NASDAQ: CBPO) reported Q1 EPS of $1.32, $0.08 better than the analyst estimate of $1.24. Revenue for the quarter came in at $91.5 million versus the consensus estimate of $85.12 million.

For earnings history and earnings-related data on China Biologic Products (CBPO) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Stantec (STN) Tops Q2 EPS by 47c
• CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance